MedTrace Logo

Comparison of Three Lancing Devices Regarding Capillary Blood Volume and Lancing Pain Intensity.

NCT03479619 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2020-02-05

No results posted yet for this study

Summary

A randomized single-blind study with the use of three lancing devices equipped with personal lancets. Every device will be studied for three lancet sizes: 28G, 30G, and 33G with the minimum and maximum puncture depth setting.

Conditions

  • Diabetes Mellitus, Type 1
  • Diabetes Mellitus, Type 2

Interventions

DEVICE

Lancing device A

Glucoject Dual Plus lancing device

DEVICE

Lancing device B

Droplet lancing device

DEVICE

Lancing device C

Commercially available lancing device

DEVICE

28 G lancet

Droplet 28 G

DEVICE

30 G lancet

Droplet personal lancet 30 G

DEVICE

33 G lancet

Droplet personal lancet 33 G

OTHER

Lancing depth setting (1)

The lowest depth setting (1)

OTHER

Lancing depth setting (5)

The highest depth setting (5)

Sponsors & Collaborators

  • Medical University of Lodz

    collaborator OTHER

  • HTL-Strefa S.A.

    lead INDUSTRY

Principal Investigators

  • Agnieszka Szadkowska, PhD,Md · Medical University of Lodz

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-06
Primary Completion
2018-05-14
Completion
2018-09-27

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03479619 on ClinicalTrials.gov